Pulmonology
Pulmonology infusion therapy addresses severe respiratory conditions including asthma, delivering advanced biologics that target airway inflammation and improve lung function.
Asthma is a chronic respiratory condition characterized by airway inflammation and narrowing that makes breathing difficult. It triggers recurring episodes of wheezing, chest tightness, shortness of breath, and coughing. Pulmonology-focused care includes advanced biologic therapies that target the immune pathways driving severe or persistent asthma, providing relief when standard treatments are insufficient.
Consult a pulmonologist if you notice ongoing shortness of breath affecting daily tasks, coughing or wheezing that doesn't improve with treatment, frequent use of rescue inhalers, or nighttime symptoms disrupting sleep. Seek emergency care for severe breathlessness, inability to speak in full sentences, or no relief after using a rescue inhaler.
Asthma results from a combination of genetic predisposition and environmental exposures. Triggers include allergens, air pollutants, respiratory infections, exercise, cold air, and stress. Occupational exposure to chemicals or industrial dust may also play a role.
Biologic therapies used in pulmonology target specific immune mechanisms driving airway inflammation. Risks include increased infection susceptibility and potential side effects from long-term corticosteroid use. Infusion therapy enables clinically monitored administration of high-efficacy biologics for optimal respiratory outcomes.
Cinqair, Fasenra, Tezspire, Nucala, Xolair